Literature DB >> 16679318

A new level of architectural complexity in the human pyruvate dehydrogenase complex.

Michaela Smolle1, Alison Elizabeth Prior, Audrey Elaine Brown, Alan Cooper, Olwyn Byron, John Gordon Lindsay.   

Abstract

Mammalian pyruvate dehydrogenase multienzyme complex (PDC) is a key metabolic assembly comprising a 60-meric pentagonal dodecahedral E2 (dihydrolipoamide acetyltransferase) core attached to which are 30 pyruvate decarboxylase E1 heterotetramers and 6 dihydrolipoamide dehydrogenase E3 homodimers at maximal occupancy. Stable E3 integration is mediated by an accessory E3-binding protein (E3BP) located on each of the 12 E2 icosahedral faces. Here, we present evidence for a novel subunit organization in which E3 and E3BP form subcomplexes with a 1:2 stoichiometry implying the existence of a network of E3 "cross-bridges" linking pairs of E3BPs across the surface of the E2 core assembly. We have also determined a low resolution structure for a truncated E3BP/E3 subcomplex using small angle x-ray scattering showing one of the E3BP lipoyl domains docked into the E3 active site. This new level of architectural complexity in mammalian PDC contrasts with the recently published crystal structure of human E3 complexed with its cognate subunit binding domain and provides important new insights into subunit organization, its catalytic mechanism and regulation by the intrinsic PDC kinase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679318      PMCID: PMC3954457          DOI: 10.1074/jbc.M601140200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  SWISS-MODEL: An automated protein homology-modeling server.

Authors:  Torsten Schwede; Jürgen Kopp; Nicolas Guex; Manuel C Peitsch
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  A comparison between the crystal and solution structures of Escherichia coli asparaginase II.

Authors:  Maciej Kozak; Stefan Jurga
Journal:  Acta Biochim Pol       Date:  2002       Impact factor: 2.149

3.  The SAXS solution structure of RF1 differs from its crystal structure and is similar to its ribosome bound cryo-EM structure.

Authors:  Bente Vestergaard; Suparna Sanyal; Manfred Roessle; Liliana Mora; Richard H Buckingham; Jette S Kastrup; Michael Gajhede; Dmitri I Svergun; Måns Ehrenberg
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

4.  Competitive interaction of component enzymes with the peripheral subunit-binding domain of the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus: kinetic analysis using surface plasmon resonance detection.

Authors:  I A Lessard; C Fuller; R N Perham
Journal:  Biochemistry       Date:  1996-12-24       Impact factor: 3.162

5.  Large differences are observed between the crystal and solution quaternary structures of allosteric aspartate transcarbamylase in the R state.

Authors:  D I Svergun; C Barberato; M H Koch; L Fetler; P Vachette
Journal:  Proteins       Date:  1997-01

6.  Different segmental flexibility of human serum transferrin and lactoferrin.

Authors:  R Vígh; L Cser; F Kilár; I Simon
Journal:  Arch Biochem Biophys       Date:  1989-11-15       Impact factor: 4.013

Review 7.  Mutations in PDX1, the human lipoyl-containing component X of the pyruvate dehydrogenase-complex gene on chromosome 11p1, in congenital lactic acidosis.

Authors:  B Aral; C Benelli; G Ait-Ghezala; M Amessou; F Fouque; C Maunoury; N Créau; P Kamoun; C Marsac
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

8.  How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydrogenase in the human pyruvate dehydrogenase complex.

Authors:  Ewa M Ciszak; Anna Makal; Young S Hong; Ananthalakshmy K Vettaikkorumakankauv; Lioubov G Korotchkina; Mulchand S Patel
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

9.  Crystal structure of eucaryotic E3, lipoamide dehydrogenase from yeast.

Authors:  T Toyoda; K Suzuki; T Sekiguchi; L J Reed; A Takenaka
Journal:  J Biochem       Date:  1998-04       Impact factor: 3.387

10.  Protein-protein interactions in the pyruvate dehydrogenase multienzyme complex: dihydrolipoamide dehydrogenase complexed with the binding domain of dihydrolipoamide acetyltransferase.

Authors:  S S Mande; S Sarfaty; M D Allen; R N Perham; W G Hol
Journal:  Structure       Date:  1996-03-15       Impact factor: 5.006

View more
  25 in total

1.  Sedimentation patterns of rapidly reversible protein interactions.

Authors:  Peter Schuck
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

2.  Successful TAT-mediated enzyme replacement therapy in a mouse model of mitochondrial E3 deficiency.

Authors:  Matan Rapoport; Lina Salman; Ofra Sabag; Mulchand S Patel; Haya Lorberboum-Galski
Journal:  J Mol Med (Berl)       Date:  2010-11-16       Impact factor: 4.599

Review 3.  Substrate channelling as an approach to cascade reactions.

Authors:  Ian Wheeldon; Shelley D Minteer; Scott Banta; Scott Calabrese Barton; Plamen Atanassov; Matthew Sigman
Journal:  Nat Chem       Date:  2016-04       Impact factor: 24.427

4.  An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α.

Authors:  Carolyn Ojano-Dirain; Lyudmyla G Glushakova; Li Zhong; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2010-07-15       Impact factor: 4.797

5.  Catalytic domain of PDC-E2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  Sandra Braun; Christoph Berg; Sandra Buck; Michael Gregor; Reinhild Klein
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

6.  1,3-Dinitrobenzene-induced metabolic impairment through selective inactivation of the pyruvate dehydrogenase complex.

Authors:  James A Miller; Stephanie A Runkle; Ronald B Tjalkens; Martin A Philbert
Journal:  Toxicol Sci       Date:  2011-05-06       Impact factor: 4.849

7.  A multipronged approach unravels unprecedented protein-protein interactions in the human 2-oxoglutarate dehydrogenase multienzyme complex.

Authors:  Jieyu Zhou; Luying Yang; Oliver Ozohanics; Xu Zhang; Junjie Wang; Attila Ambrus; Palaniappa Arjunan; Roman Brukh; Natalia S Nemeria; William Furey; Frank Jordan
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

8.  A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.

Authors:  Zongchao Han; Kristen Berendzen; Li Zhong; Ira Surolia; Nitin Chouthai; Weihong Zhao; Njeri Maina; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2008-02-21       Impact factor: 4.797

9.  Solution structure and characterisation of the human pyruvate dehydrogenase complex core assembly.

Authors:  S Vijayakrishnan; S M Kelly; R J C Gilbert; P Callow; D Bhella; T Forsyth; J G Lindsay; O Byron
Journal:  J Mol Biol       Date:  2010-03-31       Impact factor: 5.469

10.  Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.

Authors:  E M Dunbar; B S Coats; A L Shroads; T Langaee; A Lew; J R Forder; J J Shuster; D A Wagner; P W Stacpoole
Journal:  Invest New Drugs       Date:  2013-12-03       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.